Frequently Asked Questions
To learn more click on the topic which interests you. If you have a question which is not included, please email us and we will try to answer it.
Is buprenorphine treatment just switching one addiction for another?
No– With successful buprenorphine treatment as part of a complete treatment plan including counseling, the patient can put the addictive behavior into remission. The patient may still be “physically dependent” on opioids, (as they were prior to treatment) but this can be managed medically and reduced over time by a slow and gradual taper off of the medication. Physical dependence (often mistaken for “addiction”) is not a dangerous medical condition that requires treatment, addiction is. Addiction is damaging and life-threatening, while physical dependence is an inconvenience, and is normal physiology for anyone taking large doses of opioids for an extended period of time.
It is essential to understand the definition of addiction and know how it differs from physical dependence or tolerance.
The American Academy of Pain Medicine (AAPM), American Pain Society (APS), American Society of Addiction Medicine (ASAM), and NAABT recognizes these definitions below as the current accepted definitions.
I. Addiction:
Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving.II. Physical Dependence:
Physical dependence is a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist.III. Tolerance:
Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug’s effects over time.
Physical dependence and tolerance are normal physiology. Addiction is a disorder that is damaging and requires treatment.
When a patient switches from an addictive opioid to successful buprenorphine treatment, the addictive behavior often stops. In part due to buprenorphine’s long duration of action, patients do not have physical cravings prior to taking their daily dose. The drug seeking behavior ends. Patients; regain control over drug use, compulsive use ends, they are no longer using despite harm, and many patients report no cravings. Thus all of the hallmarks of addiction disappear with successful buprenorphine treatment.
Therefore, one is not trading one addiction for another addiction. They have traded a life threatening situation (addiction) for a daily inconvenience of needing to take a pill (physical dependence), as some would a vitamin. Yes the physical dependence to opioids still remains, but that is vast improvement over addiction, is not life threatening, and it can easily be managed medically..
Addiction is a brain disease that affects behavior. This addictive behavior can be devastating to the patient and their loved ones. It’s not the need to take a medication that is the problem, many people need to take a medication, but rather it is the compulsive addictive behavior to keep taking it despite doing harm to one’s self or loved ones that needs to stop. Whether or not the person takes a medication to help achieve this shouldn’t matter to anyone. If a medication helps stop the damaging addictive behavior, then that is successful treatment and not switching one addiction for another.
Sources:
The Essence of Drug Addiction- By Alan I. Leshner, Ph.D., Former Director, National Institute of Drug Abuse, National Institutes of Health
http://www.nida.nih.gov/Published_Articles/Essence.html
http://www.naabt.org/tl/The_Essence_of_Addiction.pdf
NIDA publication: The Neurobiology of Opioid Dependence: Implications for Treatment Thomas Kosten MD, Tony George MD http://www.nida.nih.gov/PDF/Perspectives/vol1no1/03Perspectives-Neurobio.pdf
The American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine - consensus document – February 2001, http://www.painmed.org/pdf/definition.pdf
American Academy of Pain Medicine - http://www.painmed.org/
American Pain Society - http://www.ampainsoc.org/
American Society of Addiction Medicine - http://www.asam.org/
2/08
Back to FAQs
What exactly is Buprenorphine?
Buprenorphine (BYOO-pre-NOR-feen) is an opioid medication used to treat opioid addiction in the privacy of a physician’s office.1 Buprenorphine can be dispensed for take home use, by prescription.1 This in addition to buprenorphine’s pharmacological and safety profile makes it an attractive treatment for patients addicted to opioids.2
Buprenorphine is different from other opioids in that it is a partial opioid agonist3. This property of buprenorphine may allow for;
- less euphoria and physical dependence*3
- lower potential for misuse*3
- a ceiling on opioid effects*3
- relatively mild withdrawal profile*3
At the appropriate dose buprenorphine treatment may:
- Suppress symptoms of opioid withdrawal2
- Decrease cravings for opioids2
- Reduce illicit opioid use2
- Block the effects of other opioids2
- Help patients stay in treatment2
* When compared with full opioid agonists (such as oxycodone and heroin)3
Buprenorphine ('bu-pre-'nôr-fen) (C29H41NO4) is a semi-synthetic opioid derived from thebaine, an alkaloid of the poppy Papaver somniferum. Buprenorphine is an opioid partial agonist. This means that, although Buprenorphine is an opioid, and thus can produce typical opioid effects and side effects such as euphoria and respiratory depression, its maximal effects are less than those of full agonists like heroin and methadone. At low doses Buprenorphine produces sufficient agonist effect to enable opioid-addicted individuals to discontinue the misuse of opioids without experiencing withdrawal symptoms. The agonist effects of Buprenorphine increase linearly with increasing doses of the drug until it reaches a plateau and no longer continues to increase with further increases in dosage. This is called the "ceiling effect." Thus, Buprenorphine carries a lower risk of abuse, addiction, and side effects compared to full opioid agonists. In fact, Buprenorphine can actually block the effects of full opioid agonists and can precipitate withdrawal symptoms if administered to an opioid-addicted individual while a full agonist is in the bloodstream. This is the result of the high affinity Buprenorphine has to the opioid receptors. The affinity refers to the strength of attraction and likelihood of a substance to bind with the opioid receptors. Buprenorphine has a higher affinity than other opioids and as such will compete for the receptor and win. It will "knock off" other opioids and occupy that receptor blocking other opioids from attaching to it. If there is enough Buprenorphine to knock the opioids off the receptors but not enough to occupy and satisfy the receptors, withdrawal symptoms can occur; in which case the treatment is more Buprenorphine until withdrawal symptoms disappear.
In October 2002, the Food and Drug Administration (FDA) approved Subutex® (buprenorphine hydrochloride) and Suboxone® tablets (buprenorphine hydrochloride and naloxone hydrochloride) for the treatment of opiate dependence. These are the only buprenorphine based products approved to treat opioid dependence (addiction).
Suboxone, contains both buprenorphine and the opiate antagonist naloxone. Naloxone has been added to Suboxone to guard against intravenous abuse of buprenorphine by individuals physically dependent on opiates. If misused by injection, the naloxone will cause immediate withdrawal in opioid dependent people, however when taken sublingually, as indicated, the naloxone is clinically insignificant.
How buprenorphine works -- Graphics (PDF)
NAABT buprenorphine treatment brochure
-
U.S. Food and Drug Administration, FDA Talk Paper, T02-38, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence
-
Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.
-
Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(suppl 2):S13-S27
Back to FAQs
What is the difference between "opioids" and "opiates"?
Opiates are drugs derived from opium. Opioids used to refer to synthetic opiates (drugs created to emulate opium, however different chemically). Now the term Opioid is used for the entire family of opiates including natural, synthetic and semi-synthetic.
- Endogenous opioid, naturally produced in the body, endorphins
- Opium alkaloids, such as morphine and codeine
- Semi-synthetic opioids such as heroin oxycodone, and Buprenorphine
- Fully synthetic opioids, such as methadone, that have structures unrelated to the opium alkaloids
Back to FAQs
What drugs are opioids?
Examples of opioids are: Painkillers such as; morphine, methadone, Buprenorphine, hydrocodone, and oxycodone. Heroin is also an opioid and is illegal.
Back to FAQs
What’s this agonist / antagonist stuff?
This is an important concept, it is why Buprenorphine is so unique as a treatment medication.
An agonist is a drug that activates certain receptors in the brain. Full agonist opioids activate the opioid receptors in the brain fully resulting in the full opioid effect. Examples of full agonists are heroin, oxycodone, methadone, hydrocodone, morphine, opium and others.An antagonist is a drug that blocks opioids by attaching to the opioid receptors without activating them. Antagonists cause no opioid effect and block full agonist opioids. Examples are naltrexone and naloxone. Naloxone is sometimes used to reverse a heroin overdose.
Buprenorphine is a partial agonist meaning, it activates the opioid receptors in the brain, but to a much lesser degree then a full agonist.
Buprenorphine also acts as an antagonist, meaning it blocks other opioids, while allowing for some opioid effect of its own to suppress withdrawal symptoms and cravings.
This is why it would be misleading to classify buprenorphine as a replacement therapy. It would be equally misleading to classify it solely as an opioid blocker. Buprenorphine is in a category of its own and therefore should not be seen as “replacement” for anything else.
Back to FAQs
How do opioids work in the brain?
Opioids attach to receptors in the brain. Normally these opioids are the endogenous variety that are created naturally in the body. Once attached, they send signals to the brain of the "opioid effect" which blocks pain, slows breathing, and has a general calming and anti-depressing effect. The body cannot produce enough natural opioids to stop severe or chronic pain nor can it produce enough to cause an overdose.
Back to FAQs
Are there exceptions when Buprenorphine may be administered by a practitioner without the DATA 2000 waiver?
Under the Narcotic Addiction Treatment Act of 1974, all practitioners who use narcotic drugs for treating opiate addiction must obtain a separate registration under 21 U.S.C. Section 823(g)(1) or a DATA 2000 Waiver under 21 U.S.C. Section 823(g)(2). However, according to the Drug Enforcement Administration (DEA), an exception to the registration requirement, known as the "three-day rule" (Title 21, Code of Federal Regulations, Part 1306.07(b)), allows a practitioner who is not separately registered as a narcotic treatment program or certified as a “waivered DATA 2000 physician,” to administer (but not prescribe) narcotic drugs to a patient for the purpose of relieving acute withdrawal symptoms while arranging for the patient’s referral for treatment, under the following conditions: 1) not more than one day’s medication may be administered or given to a patient at one time; 2) this treatment may not be carried out for more than 72 hours; and 3) this 72-hour period cannot be renewed or extended.
Back to FAQs
How does Buprenorphine work in the brain?
Opioids attach to receptors in the brain, with three main effects; reduced respiration, euphoria, decreased pain. The more opioids ingested the more of an effect. The process of opioids binding to the opioid receptors can be thought of as a mechanical union, the better the fit the more the opioid effect. Buprenorphine is different. It too binds to the receptors, however, without a perfect fit. As a result the Buprenorphine tends to occupy the receptors without all of the opioid effects. The receptor is tricked into thinking it has been satisfied with opioids without producing the feeling of euphoria, and without causing respiratory depression. This, in turn, prevents that receptor from joining with full opioids; therefore if the patient uses heroin or painkillers, they will not be able to experience any additional effect. Buprenorphine tends to stay with the receptors, blocking them, much longer then opioids do. This stickiness, is what makes Buprenorphine last so long, up to 3 days.
Back to FAQs
Are there other uses for Buprenorphine?
The Food and Drug Administration (FDA) has approved Buprenex® ( an injectable formulation of buprenorphine) to treat pain. However, by law, Buprenex cannot be used to treat opioid dependence(addiction), even by DATA-2000 wavered physicians. (Buprenex PI)
Back to FAQs
What exactly are opioid receptors?
These are protein molecules that exist on the surface of some nerve cell membranes. They provide a way for the body to experience the effects of opioids.
Back to FAQs
What is addiction?
To understand fully you must be aware of the difference between tolerance, physical dependence, and addiction:
Addiction is a primary, chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations. It is characterized by behaviors that include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, and craving. II. Physical Dependence:
Physical dependence is a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, and/or administration of an antagonist. III. Tolerance:
Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug’s effects over time. Summary:
Addiction is uncontrollable compulsive behavior caused by alterations of parts of the brain from repeated exposure to high euphoric responses.
Back to FAQs
What is withdrawal?
Withdrawal syndrome consists of a predictable group of signs and symptoms resulting from abrupt removal of, or a rapid decrease in the regular dosage of, a psychoactive substance. The syndrome is often characterized by over activity of the physiological functions that were suppressed by the drug and/or depression of the functions that were stimulated by the drug. In other words, opposite of what the drug did. If the drug suppressed depression then the person would be depressed while in withdrawal. If the substance suppressed pain then the person will experience pain while in withdrawal.
Back to FAQs
What treatments have been used for opioid addiction?
For the past 40 years there have been only a few treatments: abstinence, cold turkey, replacement therapy and medical detox. All of these treatments do little to solve the physical problem of addiction. Some replacement treatments such as methadone were introduced to reduce crime (introduced in Government-funded clinics during the Nixon Administration as 'harm reduction' for returning Vietnam Vets who became addicted to opiates overseas and also to reduce the crime statistics from the rising use of heroin in this country).(see our page on drug laws) The plan was this: if patients could get a long-acting opioid (24 hours), they would not need to get drugs as often as with heroin (4-6 hours) and thus, less crime would be committed in the procurement of the drugs and it would be possible for those to conduct fairly normal lives. It did work, however it did not stop the progression of the addiction. As time went on patients would need more and more methadone to feel the same way. It was very difficult to convince someone to decrease their dose and most people did not become drug free. They would remain addicted but now to methadone, an improvement but still an addiction.
Back to FAQs
What are examples of treatment options?
1. Buprenorphine treatment
Back to FAQs
What are the pros and cons of treatment with Methadone?
Pros:
- More than 30 years of experience in treating opioid addiction
- Daily visits give more structure to patients who need it
- Cost is usually less and may be calculated on a sliding scale based on income
- The opportunity to meet many people who share the same addiction
- Group counseling
- It is an opioid so it is able to stop the withdrawal symptoms
- It lasts for at least 24 hours
- There is no legal limit to how many patients a methadone clinic can treat
- With continued use, there is a mandatory dose increase schedule which helps patients overcome persistent cravings
- It is possible to continue to use illicit opioids while on methadone
- Patients complain that it is very difficult to detox from methadone
- Methadone treatment follows a strict protocol which makes some patients feel that they have no control over their own treatment
- Shows up in urine testing for employment
- Daily visits to the methadone clinic may be difficult for some patients who have jobs, especially when traveling distance is great.
- Daily visits make overnight travel difficult for both business and pleasure
- Some claim that it makes them feel "foggy" or like they have "cotton in their head"
- Some people find it difficult to overcome self-esteem issues in a clinic environment.
Back to FAQs
What are the pros and cons of inpatient detoxification?
Medically supervised withdrawal from opioids is the first step to treatment, but it does not constitute treatment in and of itself. It is difficult to find data reporting the long-term outcomes of patients who have been treated with inpatient detoxification.
Medical supervision and expertise is provided and patients are kept day and night until discharged. Usually they are given group counseling. Almost always patients are given medication to ease the withdrawal symptoms while they are hospitalized. Some people find it therapeutic to be away from home, jobs, family, friends, and their usual routines.Cons:
Treatment is short term. Even thirty days it is often not enough. Most times the patient is discharged without medication and because cravings continue, most find it is a matter of time before they feel compelled to give into the cravings again and relapse. Removal from the drug-saturated environment does not in and of itself, help patients to learn coping skills for resistance in order to maintain recovery long term. It can be very expensive if not government funded or covered by insurance.
Back to FAQs
What are the pros and cons of detoxification under anesthesia (Rapid Detox)?
Cons: It is not sufficient treatment for the brain disease of addiction. Detoxification is only the first step of a recovery, removing the opioids from the body does not do anything to treat the brain disease of addiction. Changes to the structure and function of the brain due to addiction may persist for months and if not treated usually result in relapse. Detox does not eliminate the cravings, and does not address the problems that lead to the addiction in the first place, unless psychosocial care is employed after the actual detoxification. It is physically dangerous, which is why it is done in an intensive care unit, and it is very expensive making it unavailable for most people. It is difficult to find data that reports the long-term outcomes of patients who are treated with inpatient detoxification. This method of detoxification is often a high profit private enterprise. Data as to actual efficacy especially over time is extremely difficult to obtain or validate. There is credible data that shows reasons not to use rapid detox. In 2005 this was printed in the prestigious Journal of the American Medical association: "Rapid opioid detoxification with opioid antagonist induction using general anesthesia has emerged as an expensive, potentially dangerous, unproven approach to treat opioid dependence." (JAMA. 2005;294:903-913)
"In general, the data do not support using general anesthesia during detoxification," said Herbert Kleber, M.D., vice chair of APA's Council on Addiction Psychiatry and a coauthor of the report. "The critical thing is not what happens during detox, but what happens after, and we found no difference between the groups. In addition, there were serious life-threatening adverse effects in the anesthesia group."(Psychiatry News October 7, 2005)
"Anesthesia-assisted detoxification should have no significant role in the treatment of opioid dependence," wrote Patrick G. O'Connor, M.D., M.P.H., in an editorial accompanying the JAMA report..."When detoxification is provided to patients, other approaches using clonidine, methadone, or buprenorphine are likely to be at least as effective as anesthesia-assisted detoxification and also are safer and far less costly." (Psychiatry News October 7, 2005) 4/2008Back to FAQs
What are the pros and cons of quitting on your own, also known as "cold turkey"?
It is not treatment for the brain disease of addiction; it does not take away the cravings, it does not address the problems that lead to the addiction in the first place; and after a period of time, it becomes too difficult to fight the cravings. Only 5% of the patients who quit cold turkey are successful long term.
Back to FAQs
Why is it called "quitting cold turkey"?
One symptom of opioid withdrawal is goose flesh (small bumps on the surface of the skin usually resulting from being cold). When someone discontinued opioids abruptly (cold turkey), they would exhibit these visible symptoms and it was noticed their skin looked like a cold turkey.
Back to FAQs
Why is counseling an important tool in the treatment process?
Physical connections create pathways in the brain that can be altered when we learn something new. These changes to the brain can be seen with medical imagery. With long term difficult things like learning to play a musical instrument, these changes can be permanent. Addiction is a learned behavior that changes the brain as well. The brain becomes conditioned to want the substance. Through counseling and other behavioral modification we can actually, in some cases, change the brain physically. By changing our environment, starting a new job, new hobbies and friends, all will alter our brain in some way. It is possible to undo some of the changes that occurred while addicted. Therapy will recondition the brain closer to pre-addiction status. This will better prepare the patient for a time when they may no longer require medication.
Back to FAQs
Who can prescribe Buprenorphine?
Any physician with a special "X" number issued by the DEA. The way the law is written, any doctor can prescribe Suboxone for treating pain, however the FDA has not granted approval for Suboxone to be used for pain, so it would be an off-label prescription. However there exists other restrictions for those who want to prescribe it for opioid addiction treatment (what the FDA approved it for). Doctors must take an 8-hour class on addiction treatment, or already possess such credentials, and then apply for a special DEA#. Once they obtain their # they are limited to treating only 30 patients at a time. (see our 30 patient limit page)
Back to FAQs
People can become addicted to anything that causes pleasure; consider gambling, sex, food, and internet. There is even a condition where patients drink so much water they thin their blood, causing some level of intoxication (hyponatremia). They are addicted to this behavior, although water is not considered addictive. Substances and activities all have some potential addiction liability. Many factors including genetics and environment contribute to someone’s potential of becoming addicted
The brain has a natural reward system that helps us to learn that things that cause pleasure are good and should be repeated. This helps our species survive by reinforcing the desire for food and sex. These activities initiate a biochemical sequence and release dopamine in the brain. This feels good and is reinforced when repeated. Some substances can trick the brain and initiate the same biochemical sequence, but to a greater and unnatural degree. The brain senses this activity as the most pleasurable and hence the most necessary for survival, and creates a memory of the activity and cravings for more. The cycle reinforces itself and can lead to addiction (uncontrollable dangerous compulsive behavior)
Research has shown that substances that reach the brain faster have a higher potential for addiction. Also substances that provide a stronger effect cause more reinforcement. This begins a cycle of euphoria then craving then euphoria, craving and so on. Each time the cycle completes it reinforces a memory in the brain, the more frequent the cycle the more reinforcing.
The potential for addiction has to do with 3 main things, the speed of the onset, the level of reinforcement (pleasure), and the duration of action. IV heroin, is fast acting, strong euphoria, short duration. This gives it a high potential for addiction. Drugs with short intense cycles provide more potential for addiction than drugs with long “flatter” cycles.
Buprenorphine has a slow onset, mild effect, and long duration, which puts it at some risk of being addictive, more than water, but less than full agonist opioids, like heroin, morphine, oxycodone, and hydrocodone.
In countries where only Subutex is available (buprenorphine without the naloxone safeguard added), some people have injected their buprenorphine, thus decreasing the onset time and increasing euphoria, this in turn increased the potential for addiction and thus more people became addicted to it. The risk of addiction is less when taken sublingually as directed.
Although there is the potential for addiction to buprenorphine, the risk is low. Few people develop the dangerous uncontrollable compulsion to buprenorphine that we know as addiction. Buprenorphine will maintain a level of physical dependence to opioids but that is manageable and can be resolved with a gradual taper once the patient is ready.
Back to FAQs
Can someone switch from methadone to buprenorphine?
It is best to SLOWLY reduce your therapeutic dose of Methadone to 30 mg a day or less for at least a week, before discontinuing it completely for at least 36 hours before starting Buprenorphine. You MUST be in mild to moderate withdrawal before you take your first dose of Buprenorphine. If you are doing well in Methadone treatment it may not be advisable to change treatments at all unless you and your doctor determine it is in your best interest.
Back to FAQs
Does insurance cover it?
Most insurance companies cover the medication itself. However many people choose to pay for it themselves to keep their condition private. There are some doctors that will only take cash. It pays to shop around. A doctor can choose what if any insurance they will accept (in some states). Every week more doctors are certified to prescribe. Some patients start with the first doctor they can get an appointment with,then find a more reasonably priced one later.
Back to FAQs
What if I miss a dose?
If you miss a dose and remember it hours later, take it upon remembering. If you forget until it is close to the time of the next day's dose, do not take a double dose. Not because you will take too much but rather you will just be wasting it, due to the ceiling effect. After being on treatment for a relatively short period of time you will feel so normal it may be difficult to remember unless you tie taking your medication to an activity you do every day at the same time. For example, after you have coffee or orange juice in the morning, or while reading the newspaper.
Back to FAQs
Why are doctors limited to only helping 30/100 people at a time?
DATA-2000 was written to allow for a variety of new drugs to be used in an office based setting by certified physicians. In 2002 Suboxone/Subutex became the first drugs that physicians could use and as of August 2007 are still the only approved medications. Without knowing the abuse potential or other social impact of these yet to be discovered drugs for addiction safeguards were built in the law. Many patients and physicians have complained that the law is too restrictive because almost every physician can prescribe potentially addictive medication but once a patient becomes addicted physicians are restricted on how many they can treat for addiction.
Back to FAQs
What if I need pain medication for surgery, or acute pain?
You will still be able to be treated for pain with elective dental or surgical procedures. Your doctors should speak with each other about the plan. They will likely stop your Buprenorphine medication, at least 36 hours before the procedure, and then when you are ready to go back on Buprenorphine you will need to be re-induced, which means stopping your pain medicine, experiencing mild withdrawal (for a very short time) and restarting your Buprenorphine.
In case of emergency, for those maintained on Buprenorphine
We never know what could happen. What if there is an emergency and you need to be treated for pain? Worse yet what if you are unconscious? A potential problem is you could be unnecessarily under-treated for pain. Since many doctors out there are still unfamiliar with Buprenorphine, there are a few documents that will be helpful. We suggest you print out a few of these and tell a loved one or your “in case of emergency” person, where they are.
- Your Bupe doctor’s name and phone number.A list on any other medications you are on or conditions you may have along with all insurance info and any other relevant medical or personal information
- This article http://www.annals.org/cgi/reprint/144/2/127.pdf you can highlight the part about buprenorphine and pain treatment.
- The PCSS Mentor brochure, the docs can call and speak with a buprenorphine expert http://www.naabt.org/documents/pcssbrochure.pdf
- PCSS-clinical guidelines- Treating acute pain in buprenorphine maintained patients: http://www.naabt.org/documents/PCSSAcutePainGuidance.pdf
- The buprenorphine illustration, for a quick understanding http://www.naabt.org/collateral/How_Bupe_Works.pdf
- A print out of the 72 hour rule, for dispensing buprenorphine in emergencies: http://www.naabt.org/documents/three-day-rule.pdf
- This article explains practical treatment issues http://www.naabt.org/documents/Practical_Conciderations%20.pdf
Keep this in a folder, jump drive, or CD, just in case of emergency. Hopefully it will never be needed.
Most of these files are PDF files and require the standard reader to view them. This comes with newer computers but if these files don’t open for you, you can download the free and virus free reader here. This is something you only have to do once and will allow you access to all kinds of information as the pdf file format is becoming more and more popular. http://www.adobe.com/products/acrobat/readstep2.html




